Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.9 EUR | +0.56% | +6.55% | +80.81% |
Evolution of the average Target Price on NewAmsterdam Pharma Company N.V.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering NewAmsterdam Pharma Company N.V.
TD Cowen | |
Scotiabank | |
RBC Capital Markets | |
Guggenheim | |
Credit Suisse | |
SVB Securities LLC | |
Jefferies & Co. | |
William Blair & Co. |
EPS Revisions
- Stock Market
- Equities
- NAMS Stock
- KH6 Stock
- Consensus NewAmsterdam Pharma Company N.V.